SynthesisFrontiers in oncology2021

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation.

Kui Zang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.